Buy GSK Consumer Healthcare, target Rs 6500: Deutsche Bank

It seems that nationwide lockdown has not much impacted the fertilizer sector. In May 2020, the Indian Fertiliser industry has witness sales growth of 25% to 5 million tonnes as compared to 4 million tonnes in the same month last year.  Coromandel International and Chambal Fertilisers have seen major sales growth in the sector. The research firm Prabhudas Lilladher is bullish on 5 stocks in the sector and among that they expect stock Insecticides India may see the upside of 82 percent, report dated June 09, 2020.

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Deutsche Bank has put buy rating on GlaxoSmithKline Consumer Healthcare as the government is considering a lower Good and Service Tax (GST) rate for malted food drinks, which get sold in small unit packs as it is consumed by mid-low income groups.

The research firm says, if lower GST rate get implemented, then it will be a net positive for the company as it can drive penetration-led growth and it will also give the company a breather in correcting the price-value equation.

The stock is trading at 26x FY2019 earnings and it has underperformed Sensex by 27 percent and 4 percent over last one and three years and Deutsche Consumer basket by 32 percent and 52 percent respectively,” the research firm said.

The firm has a price target of Rs 6500 over the next 12 months.

At 11:26 hrs GlaxoSmithKline Consumer Healthcare was quoting at Rs 5370, up Rs 2.05, or 0.04 percent on the BSE.